Articles by Lorraine Carolan

All Medical News

EHA 2016: Effect of response on associated costs and resource utilisation in MM. Professor Kwee Yong, University College Hospital, London, UK

All Medical News

EHA 2016: Smouldering Myeloma. Professor Maria-Victoria Mateos (Salamanca, Spain) discusses recent changes to the management of smouldering myeloma, her recommended work-up for these patients and the role of early treatment in this cohort.

All Medical News

EHA 2016: Molecular architecture of MM. Dr Brian Walker (University of Arkansas Medical School, Little Rock, USA) discusses his presentation in the education session on the molecular architecture of myeloma.

All Medical News

EHA 2016: What’s on the horizon in MM? Professor Sagar Lonial (Emory University School of Medicine, Atlanta, USA) gives his take on what the future looks like for myeloma.

All Medical News

EuLITE: high cut-off haemodialysis doesn’t improve outcomes in myeloma cast nephropathy. Dr Mark Cook (University Hospitals Birmingham, UK) discusses the results of the EuLITE trial looking at free light chain removal by extended haemodialysis in cast nephropathy.

All Medical News

EHA 2016: Managing multiple myeloma in elderly/frail patients. Professor Antonio Palumbo (University of Torino, Italy) discusses the impact of age on outcomes (abstract E1295) and Professor Roman Hajek (University of Ostrava, Czech Republic) talks about preferred therapeutic strategies for elderly MM patients.

Managing multiple myeloma in elderly/frail patients   Although multiple myeloma is a disease of old age, elderly patients vary a great deal in terms of fitness and ability… read more.

All Medical News

EHA 2016: Preventing clonal evolution in multiple myeloma – evidence from clinical trials. Professor Roman Hájek from the Czech Republic discussed the clinical implications of clonal evolution in multiple myeloma (MM) and summarised the latest clinical data.

Preventing clonal evolution in multiple myeloma – evidence from clinical trials by Maria Dalby Professor Roman Hájek from the Czech Republic discussed the clinical implications of clonal evolution… read more.

All Medical News

EHA 2016: How monoclonal antibodies will change the treatment of multiple myeloma. Professor Antonio Palumbo (Torino, Italy) discuss the results of the CASTOR trial and Professor Meletios-Athanasios Dimopoulos (Athens, Greece) discussing POLLUX.

How monoclonal antibodies will change the treatment of multiple myeloma  by Maria Dalby   Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France Meletios Dimopoulos, University of Athens School of… read more.

All Medical News

EHA 2016: Professor Kwee Yong (London) and Dr Mark Cook (Birmingham) share EHA highlights that will affect practice in the UK, including excitement around daratumumab and where research in the molecular stratification of disease is guiding practice. Professor Sagar Lonial (Atlanta) shares his highlights of EHA and ASCO, including data confirming the benefit of maintenance therapy and of transplant, and Professor Roman Hajek (Ostrava) gives a reality check on what the new data means for patients and haematolgists.

All Medical News

ILTS 2016: Professor John O’Grady (Kings College Hospital, London) discusses current practices in managing HCV. Also included associated article.

Treating patients with Hepatitis C infections who are on the liver transplant waiting list is not a given by Thomas R. Collins: What if patients are too sick… read more.

All Medical News

ILTS 2016: Oral Abstract highlights: Dr Leslie Lilly and Markus Selzner (both of UHN Toronto General Hospital, ON, Canada) give a round-up of the abstracts that most caught their attention at ILTS 2016.

All Medical News

ILTS 2016: Hepatocellular Carcinoma: Size and number vs biology: Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.